Skip to main content

CG Oncology, Inc.

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

CGON$74.74-1.6%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 6. Exhibits

ExhibitNumber · Exhibit Description · Incorporated by Reference · FiledHerewith
Form · Date · Number
3.1Amended and Restated Certificate of IncorporationS-1/A01/18/243.3
3.2Amended and Restated BylawsS-101/02/243.4
4.1Specimen stock certificate evidencing the shares of common stockS-1/A01/18/244.1
4.2Amended and Restated Investors’ Rights Agreement, dated July 28, 2023, as amended, by and among the Registrant and certain of its stockholdersS-1/A01/18/244.2
10.1#Employment Agreement dated April 13, 2026 between the Registrant and Jim DeTore8-K04/13/2610.1
10.2#Separation Agreement dated May 20, 2026 between the Registrant and Ambaw BelleteX
31.1Certification of Chief Executive Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002X
31.2Certification of Principal Financial Officer, as required by Rule 13a-14(a) or Rule 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002X
32.1*Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002X
32.2*Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002X
101.INSInline XBRL Instance DocumentX
101.SCHInline XBRL Taxonomy Extension Schema with Embedded Linkbase DocumentX
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.